(800) 913-2022 | CONTACT PRODUCT FINDER

News

Latest from EUROIMMUN US

About products, innovations and the company

Apr 02, 2025 | News

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Sep 19, 2024 | News

Oropouche Virus Disease Among U.S. Travelers – United States, 2024

Apr 29, 2024 | News

The subsidiary ProciseDx announces distribution agreement with Revvity’s EUROIMMUN US for the distribution of the ProciseDx platform in the United State and Canada

Mar 22, 2023 | News

EUROIMMUN Wins 2023 New Jersey Top Workplaces Award

Jun 24, 2021 | News

SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma and Delta

Apr 17, 2020 | News

ABC News: Largest antibody study could answer crucial coronavirus questions

Nov 20, 2018 | News

Membranous Nephropathy: Antibody-based diagnosis, prognosis, and disease monitoring

Feb 27, 2018 | Video

Measles and Mumps Forgotten Diseases of Recurring Relevance

Jul 27, 2017 | Video

Autoimmune Encephalitis – Anti NMDAR and Beyond

Apr 12, 2017 | News

EUROIMMUN Announces Option Agreement with Roche on Zika Virus Serology

May 28, 2016 | News

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

Apr 19, 2016 | News

Zika Virus: Anatomy of a Global Health Crisis

2025 EUROIMMUN US

Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap

START TYPING AND PRESS ENTER TO SEARCH